CREON 1224
Generic Name: pancrelipase
Pill imprint CREON 1224 has been identified as Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease.
Creon is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy.
Creon 120,000 units amylase / 24,000 units lipase / 76,000 units protease is not subject to the Controlled Substances Act.
See also related documents.
Creon Images
- Generic Name:
- pancrelipase
- Imprint:
-
CREON 1224
- Strength:
- 120,000 units amylase / 24,000 units lipase / 76,000 units protease
- Color:
- Orange / Clear
- Size:
- 11.00 mm
- Shape:
- Capsule-shape
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- hypromellose phthalate
polyethylene glycol
triethyl citrate
dimethicone
cetyl alcohol
shellac
soya lecithin
titanium dioxide
gelatin
ferric oxide red
ferric oxide yellow
sodium lauryl sulfate
- Drug Class:
- Digestive enzymes
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Solvay Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00032-1224
Advertisement
More Creon resources
Search Again
